Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
03 2019
Historique:
received: 14 03 2018
revised: 23 10 2018
accepted: 10 11 2018
pubmed: 20 11 2018
medline: 4 4 2019
entrez: 20 11 2018
Statut: ppublish

Résumé

Wilson disease (WD) is an inherited disorder of copper metabolism that leads to copper accumulation and toxicity in the liver and brain. It is caused by mutations in the adenosine triphosphatase copper transporting β gene (ATP7B), which encodes a protein that transports copper from hepatocytes into the bile. We studied ATP7B-deficient cells and animals to identify strategies to decrease copper toxicity in patients with WD. We used RNA-seq to compare gene expression patterns between wild-type and ATP7B-knockout HepG2 cells exposed to copper. We collected blood and liver tissues from Atp7b After exposure to copper, ATP7B-knockout cells had significant increases in the expression of 103 genes that regulate autophagy (including MAP1LC3A, known as LC3) compared with wild-type cells. Electron and confocal microscopy visualized more autophagic structures in the cytoplasm of ATP7B-knockout cells than wild-type cells after copper exposure. Hepatocytes in liver tissues from patients with WD and from Atp7b ATP7B-deficient hepatocytes, such as in those in patients with WD, activate autophagy in response to copper overload to prevent copper-induced apoptosis. Agents designed to activate this autophagic pathway might decrease copper toxicity in patients with WD.

Sections du résumé

BACKGROUND & AIMS
Wilson disease (WD) is an inherited disorder of copper metabolism that leads to copper accumulation and toxicity in the liver and brain. It is caused by mutations in the adenosine triphosphatase copper transporting β gene (ATP7B), which encodes a protein that transports copper from hepatocytes into the bile. We studied ATP7B-deficient cells and animals to identify strategies to decrease copper toxicity in patients with WD.
METHODS
We used RNA-seq to compare gene expression patterns between wild-type and ATP7B-knockout HepG2 cells exposed to copper. We collected blood and liver tissues from Atp7b
RESULTS
After exposure to copper, ATP7B-knockout cells had significant increases in the expression of 103 genes that regulate autophagy (including MAP1LC3A, known as LC3) compared with wild-type cells. Electron and confocal microscopy visualized more autophagic structures in the cytoplasm of ATP7B-knockout cells than wild-type cells after copper exposure. Hepatocytes in liver tissues from patients with WD and from Atp7b
CONCLUSION
ATP7B-deficient hepatocytes, such as in those in patients with WD, activate autophagy in response to copper overload to prevent copper-induced apoptosis. Agents designed to activate this autophagic pathway might decrease copper toxicity in patients with WD.

Identifiants

pubmed: 30452922
pii: S0016-5085(18)35280-6
doi: 10.1053/j.gastro.2018.11.032
pii:
doi:

Substances chimiques

Basic Helix-Loop-Helix Leucine Zipper Transcription Factors 0
Benzylamines 0
Quinazolines 0
TFEB protein, rat 0
Tcfeb protein, mouse 0
spautin-1 0
Copper 789U1901C5
TOR Serine-Threonine Kinases EC 2.7.11.1
ATP7B protein, human EC 7.2.2.8
Atp7b protein, mouse EC 7.2.2.8
Atp7b protein, rat EC 7.2.2.8
Copper-Transporting ATPases EC 7.2.2.8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1173-1189.e5

Informations de copyright

Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Elena V Polishchuk (EV)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy; ITMO University, St. Petersburg, Russia; Institute of Biosciences and Bioresources CNR, Italy.

Assunta Merolla (A)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.

Josef Lichtmannegger (J)

Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.

Alessia Romano (A)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.

Alessia Indrieri (A)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy; Department of Translational Medical Science, "Federico II" University of Naples, Naples, Italy.

Ekaterina Y Ilyechova (EY)

ITMO University, St. Petersburg, Russia; Department of Molecular Genetics, Institute of Experimental Medicine, St. Petersburg, Russia.

Mafalda Concilli (M)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.

Rossella De Cegli (R)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.

Roberta Crispino (R)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.

Marta Mariniello (M)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.

Raffaella Petruzzelli (R)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.

Giusy Ranucci (G)

Division of Metabolism, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Raffaele Iorio (R)

Department of Translational Medical Science, "Federico II" University of Naples, Naples, Italy.

Federico Pietrocola (F)

Equipe 11 labellisée Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France.

Claudia Einer (C)

Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.

Sabine Borchard (S)

Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.

Andree Zibert (A)

Klinik für Transplantationsmedizin, Universitätsklinikum Münster, Münster, Germany.

Hartmut H Schmidt (HH)

Klinik für Transplantationsmedizin, Universitätsklinikum Münster, Münster, Germany.

Elia Di Schiavi (E)

Institute of Biosciences and Bioresources CNR, Italy.

Ludmila V Puchkova (LV)

ITMO University, St. Petersburg, Russia.

Brunella Franco (B)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy; Department of Translational Medical Science, "Federico II" University of Naples, Naples, Italy.

Guido Kroemer (G)

Equipe 11 labellisée Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, UMR1138, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.

Hans Zischka (H)

Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany; Institute of Toxicology and Environmental Hygiene, Technical University Munich, Munich, Germany.

Roman S Polishchuk (RS)

Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy. Electronic address: mpolish@tigem.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH